Market Report, "AdvanDx, Inc. - Product Pipeline Analysis, 2013 Update", Published
AdvanDx (AdvanDx) is a pharmaceutical and healthcare company. The company develops and markets molecular-based in vitro diagnostic tests for the diagnosis and prevention of infectious diseases. The company's products includes development of peptide nucleic acid fluorescence in situ hybridization, whole cell analysis, fluorescence microscopy, and EVIGENE tests that provide rapid identification results for bacteria and yeast to support antibiotic therapy and improve overall patient care. AdvanDx also provides technical and customer services. The company provides its services through its research...
View full press release